BOSTON, Aug 16, 2010 (BUSINESS WIRE) -- Orthofix International (NASDAQ: OFIX) (the Company) announced today that
its Sports Medicine Division, Breg, has launched the FUSION(R)
XT knee brace with its innovative new AirTech(TM) system. Designed to
improve comfort and fit, AirTech is a complete system of air mesh vents
and grooved channel frame pads that increase airflow throughout the
brace. The system allows cool air in and moves warm air and moisture
away from the skin, improving patient comfort. The new pad technology is
also designed to reduce pinching and help alleviate pressure points.
In addition to AirTech innovation, the FUSION XT brace also includes
pivot-point strap tabs that are longer, flexible and more durable. These
new pivot-points enable patients to independently position the straps in
order to provide a superior fit.
"The enhanced FUSION XT brace provides significant advancements in
performance and durability for high impact sports like football," said
Alan Milinazzo, President and CEO of Orthofix. "The AirTech system
represents our continued focus on making the FUSION line of braces the
standard in patient comfort, fit and compliance, and also demonstrates
Orthofix's ongoing commitment to product innovation."
The U.S. market for ligament braces is estimated to be approximately
$167 million in 2010, with an annual growth rate of 3.8%.
Available now on the FUSION XT Ligament brace, the Company plans to also
incorporate the AirTech system into its FUSION and FUSION Women's braces.
For more information about Breg's portfolio of products, including
FUSION braces, visit www.orthofix.com
or www.breg.com.
About Orthofix
Orthofix International, N.V. is a global medical device company offering
a broad line of minimally invasive surgical, and non-surgical, products
for the spine, orthopedic, and sports medicine market sectors that
address the lifelong bone-and-joint health needs of patients of all
ages-helping them achieve a more active and mobile lifestyle. Orthofix's
products are widely distributed around the world to orthopedic surgeons
and patients via Orthofix's sales representatives and its subsidiaries,
including BREG, Inc. and via partnerships with other leading orthopedic
product companies. In addition, Orthofix collaborates with leading
medical institutions such as the Musculoskeletal Transplant Foundation,
the Orthopedic Research and Education Foundation, and The University of
Medicine and Dentistry of New Jersey. For more information about
Orthofix, please visit www.orthofix.com.
SOURCE: Orthofix International
Orthofix International, N.V.
Dan Yarbrough, 617-912-2903
Vice President of Investor Relations
danyarbrough@orthofix.com
Copyright Business Wire 2010